Elshahawy M - Search Results

1

Efficient photocatalytic remediation of lerui acid brilliant blue dye using radiation- prepared carboxymethyl cellulose/acrylic acid hydrogel supported by ZnO@Ag.

Elshahawy MF, Ahmed NA, Gad YH, Ali AE. Elshahawy MF, et al. Int J Biol Macromol. 2024 Mar;262(Pt 2):129946. doi: 10.1016/j.ijbiomac.2024.129946. Epub 2024 Feb 8. Int J Biol Macromol. 2024. PMID: 38340936

2

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.

Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.

3

Formation of plasmonic silver nanoparticles by glucosamine reduction: Application to a colorimetric sensor for determination of glucosamine in its pharmaceutical preparations.

Abdel Hamid M, Habib A, Mabrouk M, Hammad S, Elshahawy M. Abdel Hamid M, et al. Among authors: elshahawy m. J Pharm Biomed Anal. 2023 Nov 30;236:115705. doi: 10.1016/j.jpba.2023.115705. Epub 2023 Sep 8. J Pharm Biomed Anal. 2023. PMID: 37690186

4

Early Melanoma Detection Based on a Hybrid YOLOv5 and ResNet Technique.

Elshahawy M, Elnemr A, Oproescu M, Schiopu AG, Elgarayhi A, Elmogy MM, Sallah M. Elshahawy M, et al. Diagnostics (Basel). 2023 Aug 30;13(17):2804. doi: 10.3390/diagnostics13172804. Diagnostics (Basel). 2023. PMID: 37685342 Free PMC article.

5

Dual fluorescence-colorimetric sensor based on silver nanoparticles for determination of tobramycin in its pharmaceutical preparations.

Abdel Hamid M, Habib A, Mabrouk M, Hammad S, Elshahawy M. Abdel Hamid M, et al. Among authors: elshahawy m. Spectrochim Acta A Mol Biomol Spectrosc. 2023 Dec 15;303:123172. doi: 10.1016/j.saa.2023.123172. Epub 2023 Jul 20. Spectrochim Acta A Mol Biomol Spectrosc. 2023. PMID: 37494813

6

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.

Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2023 Sep 1;46(9):1721. doi: 10.2337/dc23-er09. Diabetes Care. 2023. PMID: 37310695 Free PMC article. No abstract available.

7

Radiation synthesis and photocatalytic performance of floated graphene oxide decorated ZnO/ alginate-based beads for methylene blue degradation under visible light irradiation.

Elshahawy MF, Ahmed NA, Mohamed RD, Ali AE, Raafat AI. Elshahawy MF, et al. Int J Biol Macromol. 2023 Jul 15;243:125121. doi: 10.1016/j.ijbiomac.2023.125121. Epub 2023 May 30. Int J Biol Macromol. 2023. PMID: 37263325

8

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries.

National Institute for Health and Care Research Global Health Research Unit on Global Surgery. National Institute for Health and Care Research Global Health Research Unit on Global Surgery. Br J Surg. 2023 Jun 12;110(7):804-817. doi: 10.1093/bjs/znad092. Br J Surg. 2023. PMID: 37079880 Free PMC article.

9

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.

Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.

10

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.

Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page